Lulizumab pegol (BMS-931699) is an anti-CD28 antibody antagonist that inhibits T-cell proliferation, offering potential therapeutic applications for kidney transplantation and autoimmune disease research [1].
CAS Number:
[1421830-13-8]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted